Inherited Retinal Diseases: Why Genetic Testing Is Key to Diagnosis and Future Treatment:

Suspense crime, Digital Desk : Inherited retinal diseases (IRDs) are genetic syndromes which have an impact on the retina, a light-sensitive structure located at the backside of the eye. These disorders may result in progressive vision impairment or complete vision loss. IRDs include:

Retinitis pigmentosa (RP)

Stargardt disease

Cone-rod dystrophy

Leber congenital amaurosis (LCA)

The aforementioned diseases may occur anywhere between infancy to adulthood. Clinical diagnosis is often complicated due to overlapping symptoms such as night blindness and gradual vision loss.

The Role of Genetic Testing in IRD Diagnosis and Management

As highlighted by Dr. N Soumittra, Head of Ophthalmology at MedGenome, more than 200 genes have been associated with IRDs. Identifying specific mutation through genetic testing is crucial to make an IRD diagnosis as it helps design a treatment plan, facilitate research, and establish effective IRD management protocols.

1. Early and Accurate Diagnosis

Most conventional IRD eye examinations don’t provide the required differentiation between the disorders. Supplementary testing such as Genetic testing:

Identifies the infection earlier such as before symptoms arise.

Clarifies diagnosis and hence lessens ambiguity for the patient and the medical professionals.

2. Predicting Disease Progression

There are some IRDs whose symptoms appear in early childhood while others emerge in teenage years or even adulthood.

“Knowing the genetic root of the disease enables doctors to estimate how it might progress,” says Dr. Soumittra.

This assists in developing long-term care and follow-up strategies aimed at each patient's individual risk profile.

3. Identification of Treatment Gaps

To the best of my knowledge, there is no universal treatment available. Nonetheless, there is potential in gene therapy. For instance, some countries have already adopted treatments for RPE65 gene mutations. Genetic testing:

Determines the eligibility of patients for certain gene therapies
Justifies their participation in clinical trials

4. Supporting Family Planning Decisions

Testing parents and potential parents is useful because it provides useful information about carrier status:

Helps estimate the likelihood of transmitting the condition
Guides reproductive decisions based on factual evidence

5. Diagnosing Syndromic IRDs

Included in some of the organ systems-related syndromes are certain retinal diseases, such as:

Hearing
Kidney
Neurology

Timely genetics facilitates eye care but is really looking beyond just eye care to enable comprehensive medical care that has been made previously possible.

6. Supporting New Research and Future Treatment Principles

The results of every genetic test augment international repositories, helping to create:
New avenues for treatment, such as gene editing and RNA-based therapies
Having a clearer understanding of the mechanisms behind the disease

“Genetic information is vital to IRD treatment, without which IRD treatment could be very difficult,” Dr. Soumittra explains.